Biofrontera AG B8F-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/14/21 CEST
2.35quote price arrow up+0.03 (+1.29%)
Volume
2,500
52 week range
2.28 - 5.50

...

Loading . . .
  • Open2.33
  • Day High2.35
  • Day Low2.33
  • Prev Close2.35
  • 52 Week High5.50
  • 52 Week High Date08/14/20
  • 52 Week Low2.28
  • 52 Week Low Date04/21/21

Key Stats

  • Market Cap161.95M
  • Shares Out56.72M
  • 10 Day Average Volume13,849.36
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-20.34

KEY STATS

  • Open2.33
  • Day High2.35
  • Day Low2.33
  • Prev Close2.35
  • 52 Week High5.50
  • 52 Week High Date08/14/20
  • 52 Week Low2.28
  • 52 Week Low Date04/21/21
  • Market Cap161.95M
  • Shares Out56.72M
  • 10 Day Average Volume13,849.36
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-20.34

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-9.79
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biofrontera AG

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients...
Ludwig Lutter
Chief Financial Officer
Address
Hemmelrather Weg 201
Leverkusen
51377
Germany